Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fuji
Cantor Fitzgerald
McKesson
Daiichi Sankyo
Federal Trade Commission
Citi
Chinese Patent Office
Moodys
Medtronic

Generated: January 18, 2018

DrugPatentWatch Database Preview

BUMETANIDE Drug Profile

« Back to Dashboard

Drug patent expirations by year for BUMETANIDE
Pharmacology for BUMETANIDE
Medical Subject Heading (MeSH) Categories for BUMETANIDE

US Patents and Regulatory Information for BUMETANIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athenex Inc BUMETANIDE bumetanide INJECTABLE;INJECTION 074441-001 Jan 27, 1995 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-002 Oct 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral BUMETANIDE bumetanide INJECTABLE;INJECTION 074613-001 Nov 18, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz BUMETANIDE bumetanide TABLET;ORAL 074700-001 Nov 21, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-003 Oct 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz BUMETANIDE bumetanide TABLET;ORAL 074700-003 Nov 21, 1996 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira BUMETANIDE bumetanide INJECTABLE;INJECTION 074160-001 Oct 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira BUMETANIDE bumetanide INJECTABLE;INJECTION 074332-001 Oct 31, 1994 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-001 Oct 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int BUMETANIDE bumetanide INJECTABLE;INJECTION 079196-001 Apr 30, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Merck
McKinsey
Mallinckrodt
AstraZeneca
Julphar
Colorcon
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot